AI Article Synopsis

  • Tumor deposits (TDs) are a significant factor in colorectal cancer, affecting about 20% of patients and leading to poorer survival outcomes.
  • The TNM classification system has undergone several revisions since 1997 to categorize TDs, but recent evidence suggests these changes, particularly the N1c category, have not fully optimized the system's prognostic capabilities.
  • Researchers advocate for a "counting method" that counts individual TDs alongside positive lymph nodes, providing more accurate prognostic data and prompting a call for a reevaluation of TD staging practices globally to ensure patients receive appropriate treatment.

Article Abstract

Tumor deposits (TDs) are discontinuous tumor spread in the mesocolon/mesorectum which is found in approximately 20% of colorectal cancer (CRC) and negatively affects survival. We have a history of repeated revisions on TD definition and categorization in the tumor-node-metastasis (TNM) system leading to stage migration. Since 1997, TDs have been categorized as T or N factors depending on their size (TNM5) or contour (TNM6). In 2009, TNM7 provided the category of N1c for TDs in a case without positive lymph nodes (LNs), which is also used in TNM8. However, increasing evidence suggests that these revisions are suboptimal and only "partially" successful. Specifically, the N1c rule is certainly useful for oncologists who are having difficulty with TDs in a case with no positive LNs. However, it has failed to maximize the value of the TNM system because of the underused prognostic information of individual TDs. Recently, the potential value of an alternative staging method has been highlighted in several studies using the "counting method." For this method, all nodular type TDs are individually counted together with positive LNs to derive the final pN, yielding a prognostic and diagnostic value that is superior to existing TNM systems. The TNM system has long stuck to the origin of TDs in providing its categorization, but it is time to make way for alternative options and initiate an international discussion on optimal treatment of TDs in tumor staging; otherwise, a proportion of patients end up missing an opportunity to receive the optimal adjuvant treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043773PMC
http://dx.doi.org/10.1002/ags3.12652DOI Listing

Publication Analysis

Top Keywords

tnm system
16
tumor deposits
8
colorectal cancer
8
tds
8
tds case
8
case positive
8
positive lns
8
tnm
5
tumor
4
deposits colorectal
4

Similar Publications

Prognostic Accuracy of ypTNM Stage in Patients with Pancreatic Cancer in the Era of Modern Neoadjuvant Therapy.

Ann Surg Oncol

January 2025

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Background: The American Joint Committee on Cancer (AJCC) 8th edition TNM staging manual, which provided ypTNM for patients undergoing neoadjuvant therapy (NAT), has not been comparatively assessed against pTNM for prognosis in pancreatic cancer. This study aimed to compare the prognosis between ypTNM and pTNM stages.

Patients And Methods: Clinicopathological data from 586 patients who underwent pancreatic cancer surgery at a tertiary center between 2018 and 2022 were analyzed to compare survival outcomes between ypTNM and pTNM stages and identify prognostic factors.

View Article and Find Full Text PDF

Background: Tumor microenvironment (TME) plays a crucial role in tumor growth and metastasis. Exploring biomarkers that are significantly associated with TME can help guide individualized treatment of patients.

Methods: We analyzed the expression and survival of P4HB in pan-cancer through the TCGA database, and verified the protein level of P4HB by the HPA database.

View Article and Find Full Text PDF

Background: This study aimed to investigate the prognostic impact of lymph node metastasis (LNM) on patients with colorectal cancer liver metastasis (CRLM) and elucidate the underlying immune mechanisms using multiomics profiling.

Methods: We enrolled patients with CRLM from the US Surveillance, Epidemiology, and End Results (SEER) cohort and a multicenter Chinese cohort, integrating bulk RNA sequencing, single-cell RNA sequencing and proteomics data. The cancer-specific survival (CSS) and immune profiles of the tumor-draining lymph nodes (TDLNs), primary tumors and liver metastasis were compared between patients with and without LNM.

View Article and Find Full Text PDF

Background: The International Medullary Thyroid Carcinoma Grading System (IMTCGS) was recently introduced in medullary thyroid carcinoma (MTC). This study aimed to assess the predictive value of the IMTCGS for disease response and survival, and compare its predictive ability with that of other traditional risk factors in a Chinese MTC cohort.

Methods: The data of 137 MTC patients undergoing initial surgery between January 2004 and June 2023 were included for analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer presents a major global health issue, complicated by its diverse characteristics and resistance to treatment, while current staging systems fail to fully represent its biological complexity.
  • This study investigated MyD88, an important protein in inflammatory responses, using advanced techniques like RNA sequencing and immunohistochemistry to examine its role in breast cancer.
  • Elevated MyD88 levels correlated with better patient outcomes and increased sensitivity to chemotherapy, suggesting its potential as a predictive biomarker and a valuable tool for personalized medicine in treating breast cancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!